SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.

Rapport

Vertraagde tijd Hong Kong Stock Exchange - 10:08 24-06-2022
3.400	HKD		+1.49%

08/06	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Ontvangt het bericht van aanvaarding van het Nationaal Beheer Medische Producten van de Volksrepubliek China	CI
29/04	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Maakt winstcijfers bekend voor het eerste kwartaal eindigend op 31 maart 2022	CI
28/03	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Stelt slotdividend voor het op 31 december 2021 geëindigde jaar voor, betaalbaar op 26 augustus 2022	CI

Nieuws

Andere talen

Officiële publicaties

Sectornieuws

Nieuws in andere talen op SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.

19/06	Certain A Shares of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. are subject ..
08/06	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Receives the Acceptance Notice Is..
29/04	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Reports Earnings Results for the ..
28/03	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Proposes Final Dividend for the Y..
25/02	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2021	US FDA Accepts Fudan-Zhangjiang Bio's Clinical Trial Application for Port Wine Stain Dr..
2021	Fudan-Zhangjiang Bio Arm Enrolls First Patient in Clinical Trial of Generic Primary Bil..
2021	Chinese Regulators Approve Clinical Trial of Fudan-Zhangjiang Bio for Ulcerative Coliti..
2021	China Accepts Fudan-Zhangjiang Bio's Clinical Trial Application for Dermatitis Treatmen..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Receives the Acceptance Notice b..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Appoints Huang Jian as Chairman ..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Chinese Regulators Accept Shanghai Fudan-Zhangjiang..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Receives Acceptance Notice Issue..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Announces Resignation of Tang Yu..
2021	SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMA : 688505) added to S&P Global BMI Index
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Interim results announcement for the six months end..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. commences an Equity Buyback Plan..
2021	SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMA : 688505) added to Shanghai Stock Exchange Composite ..
2021	SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMA : 688505) added to Shanghai Stock Exchange A Share In..
2021	Certain A Shares of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. are subject ..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Supplemental circular
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Zhangjiang Swings to Profit in Q1 as Revenue Balloo..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Chinese Regulators Accept Fudan-Zhangjiang Bio's Cl..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Chinese Regulators Accept Fudan-Zhangjiang Bio's Cl..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Indicative announcement-fda018 antibody drug conjug..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Receives Acceptance Notice for t..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Circular
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Proxy form for class meeting of holders of h shares
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : (1) proposed adoption of the 2021 restricted incent..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Zhangjiang Books Lower Profit, Revenue in 2020; Sha..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Fudan-Zhangjiang Bio to Acquire Nearly 40% Stake in..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Discloseable transaction-acquisition of equity inte..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Adjustments in the roles of members of the nominati..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Utilisation of part of the over subscription procee..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Announces Nomination Committee C..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Recommends Final Dividend for th..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Inside information-proposed grant of general mandat..
2021	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. entered into equity transfer agr..
2021	Shanghai Handu Pharmaceutical Technology Co., Limited announced that it expects to rece..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Fudan-Zhangjiang Bio Unit Wins Marketing Approval i..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Inside information - announcement of preliminary an..
2021	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Indicative announcement on obtaining drug registrat..
2020	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2020	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Interim Report For the Six Months Ended 30 June 202..
2020	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2020	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2020	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Approves Election of Tang Yu Kua..
2020	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2020	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Circular
2020	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Proposes Dividend for the Year E..
2020	Shenyang Rongke Rongtuo Health Data Industry Equity Investment Partnership (Limited Par..
2020	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Articles of association
2020	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Poll results of extraordinary general meeting, clas..
2020	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Voluntary announcement-precautions during the epide..
2020	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Announces Earnings Guidance for ..
2019	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Reports Earnings Results for the ..
2019	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Inside information-unaudited consolidated financial..
2019	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Poll results of extraordinary general meeting
2019	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Further announcement on suspension of review by the..
2019	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Announcement on suspension of review by the listing..
2019	SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Continuing connected transactions-sales and distrib..
2019	SHANGHAI FUDAN ZHANGJIANG BIO PHARM : Extraordinary general meeting reply slip
2019	SHANGHAI FUDAN ZHANGJIANG BIO PHARM : Proxy form for extraordinary general meeting
2019	SHANGHAI FUDAN ZHANGJIANG BIO PHARM : Continuing connected transactions-sales and distribu..
2019	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Signs Sales and Distribution Agr..
2019	SHANGHAI FUDAN ZHANGJIANG BIO PHARM : Announcement on resumption of the review process of ..
2019	SHANGHAI FUDAN ZHANGJIANG BIO PHARM : Interim Report For the Six Months Ended 30 June 2019
2019	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2019	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Provides Earnings Guidance for t..
2019	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. entered into state-owned equity ..
2019	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Proposes Appointment of Members ..

1 2 Volgende

Volgende evenement op SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.

05/08/22

Eerste halfjaar 2022 Cijferpublicaties (schatting)

De agenda van het bedrijf

Komende gebeurtenissen in de sector

04/08/22	KYOWA KIRIN CO., LTD. : Eerste halfjaar 2022 Cijferpublicaties
04/08/22	MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN : Eerste halfjaar 2022 Cijferpublicaties
19/08/22	SK BIOPHARMACEUTICALS CO., LTD. : Eerste halfjaar 2022 Cijferpublicaties (schatting)
25/08/22	BETTA PHARMACEUTICALS CO., LTD. : Eerste halfjaar 2022 Cijferpublicaties (schatting)

Meer evenementen

Sector

Gezondheidszorg
	Farmaceutisch en medisch onderzoek
		Farmaceutische producten
			Farmaceutische producten
				Specialiteit & Geavanceerde Farmaceutische Producten